ALNT vs ASML

Allient Inc. (ALNT) exhibits a Piotroski F-Score of 4, indicating a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The stock trades at a premium to its Graham Number ($21.18) and intrinsic value ($33.04), reflecting strong growth expectations rather than undervaluation. Despite elevated valuation metrics—P/E of 55.66 and forward P/E of 20.19—earnings and revenue growth are robust, with YoY earnings up 110.1% and revenue up 17.5%. Insider selling in the last six months and a bearish technical trend temper the outlook, but consistent earnings beats and a strong analyst buy consensus support upside potential. Price trades at a 88.7% premium to fair value estimate ($33.04), limiting near-term upside from a valuation perspective.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.